This patent will extend VistaGen’s intellectual property portfolio for pluripotent stem cell culture systems that produce human cells of the endoderm lineage, including liver, lung, pancreas, parathyroid and
YLB will be jointly managed by both partners and will be responsible for conducting clinical development of certain Biosimilars including regulatory filings and obtaining marketing authorizations in Japan.
Through this partnership, BettrLife’s mobile health software will be integrated with Viridian’s Maestro population health management platform, allowing users to interact directly with Viridian health coaches. Through integration
TouchMD is an interactive software platform that helps specialty physicians engage patients in the education process before, during and after the consultation. The software allows physicians and staff
The new product line for the pharmaceutical industry expands the established EFLA brand, offering increased value to the pharmaceutical industry plus expertise in building a supply chain for
Pure is part of the Elsevier Research Intelligence portfolio of tools and services. Over the years, UrFU, one of the leading Russian universities, has focused on increasing the
The team, led by Dr Matthew Hardman have been awarded an MRC Industry Collaboration Agreement (MICA) grant from the UK Medical Research Council to help fund the investigations.
This patent expands the intellectual property for the Company’s opioid abuse deterrent technology. Elite now has three US patents and one Canadian patent issued in this area with
The early administration of plasma has an important role in reducing battlefield mortality rates, and therefore the USAMMDA has prioritized the development of a freeze-dried plasma product. Currently,
Under the agreement, HEC will supply insulin aspart, the active pharmaceutical ingredient (API) in Novolog(R), which Biodel will use to formulate aspart based ultra-rapid-acting insulin formulations. Biodel has
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.